Come up with a name for your new list and we'll add to it:
NeuroDerm raised a round of funding on October 18, 2017. Investors include
Mitsubishi Tanabe Pharma.
NeuroDerm is a clinical-stage pharmaceutical company developing central nervous system (CNS) product candidates that are designed to overcome major deficiencies of current treatments and achieve enhan…